This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Korea Atomic Energy Research Institute. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2025
Title: Innovations of Yong Dae Park
Introduction
Yong Dae Park is a notable inventor based in Jeollabuk-do, South Korea. He has made significant contributions to the field of biomedical research, particularly in the detection of beta-amyloid, which is crucial for understanding various neurodegenerative diseases.
Latest Patents
Yong Dae Park holds 2 patents that showcase his innovative work. His first patent is for a water-soluble compound for the detection of beta-amyloid. This invention relates to a compound that possesses excellent water-soluble properties, enabling the creation of a formulation for detecting beta-amyloid. This compound can be particularly useful in retinal imaging for the detection of beta-amyloid. His second patent involves a method for detecting amyloid aggregates using styrylpyridazine-one derivatives. This invention includes a composition for diagnosing beta-amyloid aggregation disease and a diagnostic kit that utilizes this composition to provide essential information for diagnosing such diseases.
Career Highlights
Yong Dae Park is affiliated with the Korea Atomic Energy Research Institute, where he continues to advance his research and innovations. His work is instrumental in the ongoing efforts to develop effective diagnostic tools for neurodegenerative conditions.
Collaborations
Some of his notable coworkers include Jeong Hoon Park and Yong Jin Yoon, who contribute to the collaborative research environment at the Korea Atomic Energy Research Institute.
Conclusion
Yong Dae Park's contributions to the field of biomedical research through his patents highlight his innovative spirit and dedication to advancing medical diagnostics. His work is paving the way for better understanding and detection of critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
